← Back to Treatments
🏅 FDA Orphan Designation

Luveris

Recombinant human luteinizing hormone

Manufacturer: EMD Serono, Inc.

Indicated for:
Rare disorder with female infertility due to a congenital hypogonadotropic hypogonadismOrphanKallmann syndrome

FDA-Approved Indications (2)

Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hy…

Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hy…

Population: women

Indications & Usage

Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).

💙 Support Programs

View all →
Luveris
EMD Serono, Inc.
Apply ↗
Luveris
EMD Serono, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.